Form 8-K - Current report:
SEC Accession No. 0001193125-16-714192
Filing Date
2016-09-20
Accepted
2016-09-20 09:23:59
Documents
5
Period of Report
2016-09-19
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d249853d8k.htm 8-K 44533
2 EX-2.1 d249853dex21.htm EX-2.1 512817
3 EX-99.1 d249853dex991.htm EX-99.1 81483
4 EX-99.2 d249853dex992.htm EX-99.2 30933
5 GRAPHIC g249853ex992pg001.jpg GRAPHIC 22265
  Complete submission text file 0001193125-16-714192.txt   702129
Mailing Address 701 GATEWAY BLVD SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 701 GATEWAY BLVD SUITE 300 SOUTH SAN FRANCISCO CA 94080 650-741-6625
Tobira Therapeutics, Inc. (Filer) CIK: 0001311596 (see all company filings)

IRS No.: 030422069 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35953 | Film No.: 161893061
SIC: 2834 Pharmaceutical Preparations